IL33538A - Pyramidine-2-yl-imide-azulium salts and a process for their preparation - Google Patents
Pyramidine-2-yl-imide-azulium salts and a process for their preparationInfo
- Publication number
- IL33538A IL33538A IL33538A IL3353869A IL33538A IL 33538 A IL33538 A IL 33538A IL 33538 A IL33538 A IL 33538A IL 3353869 A IL3353869 A IL 3353869A IL 33538 A IL33538 A IL 33538A
- Authority
- IL
- Israel
- Prior art keywords
- lower alkyl
- pyrimidinyl
- hydrogen
- imidazolium
- phenyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 5
- WQMHSYISOHEFSU-UHFFFAOYSA-O 2-(1H-imidazol-1-ium-1-yl)pyrimidine Chemical class N1=C(N=CC=C1)[NH+]1C=NC=C1 WQMHSYISOHEFSU-UHFFFAOYSA-O 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 claims description 4
- 150000005695 2-halopyrimidines Chemical class 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- -1 1-substituted imidazole Chemical class 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 150000002431 hydrogen Chemical group 0.000 claims 3
- 150000004820 halides Chemical class 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-O 1-methylimidazole Chemical compound CN1C=C[NH+]=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-O 0.000 claims 1
- WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229960004592 isopropanol Drugs 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- GIWQSPITLQVMSG-UHFFFAOYSA-N 1,2-dimethylimidazole Chemical compound CC1=NC=CN1C GIWQSPITLQVMSG-UHFFFAOYSA-N 0.000 description 1
- KKKDZZRICRFGSD-UHFFFAOYSA-N 1-benzylimidazole Chemical compound C1=CN=CN1CC1=CC=CC=C1 KKKDZZRICRFGSD-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 1
- NPZNQGNWMDRMGV-UHFFFAOYSA-M 2-(2,3-dimethylimidazol-3-ium-1-yl)pyrimidine;chloride Chemical compound [Cl-].C1=C[N+](C)=C(C)N1C1=NC=CC=N1 NPZNQGNWMDRMGV-UHFFFAOYSA-M 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78636968A | 1968-12-23 | 1968-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL33538A0 IL33538A0 (en) | 1970-02-19 |
| IL33538A true IL33538A (en) | 1972-08-30 |
Family
ID=25138387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL33538A IL33538A (en) | 1968-12-23 | 1969-12-15 | Pyramidine-2-yl-imide-azulium salts and a process for their preparation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3557114A (en, 2012) |
| BE (1) | BE743510A (en, 2012) |
| BR (1) | BR6914814D0 (en, 2012) |
| CH (1) | CH522660A (en, 2012) |
| DE (1) | DE1964282A1 (en, 2012) |
| ES (1) | ES374692A1 (en, 2012) |
| FR (1) | FR2026902B1 (en, 2012) |
| GB (1) | GB1252847A (en, 2012) |
| IL (1) | IL33538A (en, 2012) |
| NL (1) | NL6918402A (en, 2012) |
| NO (1) | NO123610B (en, 2012) |
| SE (1) | SE353722B (en, 2012) |
| ZA (1) | ZA698862B (en, 2012) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE43313B1 (en) | 1975-09-03 | 1981-01-28 | Pfizer | Quaternary salts as hypoglycemic agents |
| EP0421266A1 (de) * | 1989-10-06 | 1991-04-10 | BASF Aktiengesellschaft | Azolylpyrimidin- und -triazinderivate und sie enthaltende Mittel |
| US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
| ZA9610687B (en) * | 1995-12-22 | 1997-09-29 | Smithkline Beecham Corp | Novel synthesis. |
| AU715900B2 (en) * | 1996-01-11 | 2000-02-10 | Smithkline Beecham Corporation | Novel substituted imidazole compounds |
| US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| AP9700912A0 (en) | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
| US5929076A (en) * | 1997-01-10 | 1999-07-27 | Smithkline Beecham Corporation | Cycloalkyl substituted imidazoles |
| US6239279B1 (en) * | 1998-12-16 | 2001-05-29 | Smithkline Beecham Corporation | Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives |
-
1968
- 1968-12-23 US US786369A patent/US3557114A/en not_active Expired - Lifetime
-
1969
- 1969-12-05 BR BR214814/69A patent/BR6914814D0/pt unknown
- 1969-12-08 NL NL6918402A patent/NL6918402A/xx unknown
- 1969-12-15 IL IL33538A patent/IL33538A/en unknown
- 1969-12-18 ES ES374692A patent/ES374692A1/es not_active Expired
- 1969-12-18 SE SE17485/69A patent/SE353722B/xx unknown
- 1969-12-19 GB GB1252847D patent/GB1252847A/en not_active Expired
- 1969-12-22 DE DE19691964282 patent/DE1964282A1/de active Pending
- 1969-12-22 FR FR696944342A patent/FR2026902B1/fr not_active Expired
- 1969-12-22 NO NO5064/69A patent/NO123610B/no unknown
- 1969-12-22 ZA ZA698862*A patent/ZA698862B/xx unknown
- 1969-12-22 CH CH1903269A patent/CH522660A/de not_active IP Right Cessation
- 1969-12-22 BE BE743510D patent/BE743510A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH522660A (de) | 1972-06-30 |
| ZA698862B (en) | 1971-07-28 |
| DE1964282A1 (de) | 1970-07-09 |
| GB1252847A (en, 2012) | 1971-11-10 |
| BE743510A (en, 2012) | 1970-06-22 |
| FR2026902A1 (en, 2012) | 1970-09-25 |
| SE353722B (en, 2012) | 1973-02-12 |
| ES374692A1 (es) | 1972-01-01 |
| NO123610B (en, 2012) | 1971-12-20 |
| IL33538A0 (en) | 1970-02-19 |
| FR2026902B1 (en, 2012) | 1973-08-10 |
| US3557114A (en) | 1971-01-19 |
| BR6914814D0 (pt) | 1973-03-08 |
| NL6918402A (en, 2012) | 1970-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870000206B1 (ko) | 퓨로-(3,4-c)-피리딘 유도체의 제조방법 | |
| US3629473A (en) | Anti-inflammatory agents and compositions | |
| US4213994A (en) | Imidazolyl-(2)-carbinols having hypolipidemic action and process for preparing them | |
| CA1138334A (en) | Pharmaceutical preparations containing certain urea derivatives | |
| IE51342B1 (en) | Substituted pyrazinyl-1,2,4-oxadiazol-5-ones,a process for preparing same and a pharmaceutical composition containing same | |
| EP0679656A1 (en) | Improvements in platinum complexes | |
| IL33538A (en) | Pyramidine-2-yl-imide-azulium salts and a process for their preparation | |
| US4093728A (en) | Triazoloisoindoles | |
| SU1424733A3 (ru) | Способ получени солей имидазола | |
| SK283734B6 (sk) | Kryštálové modifikácie 1-(2,6-difluórbenzyl)-1H-1,2,3-triazol-4- karboxamidu, farmaceutické prípravky, ktoré ich obsahujú, a ich použitie | |
| US3923994A (en) | Anti-arthritic compositions comprising a 3-aryl 2-thiohydantoin and methods of producing anti-arthritic acitvity | |
| JPS61109767A (ja) | オキシンドール抗炎症剤 | |
| IL43079A (en) | 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them | |
| PL159840B1 (pl) | dropirydyn PL PL | |
| JPS58188879A (ja) | シプロヘプタジン−３−カルボン酸及び構造的に関連した化合物のエステル | |
| US3535319A (en) | Pyrimidinyl or pyrazinoyl-4-imino-dihydropyridine compounds and process | |
| US3845071A (en) | Imidazo(1,2-a)azacycloalkanes | |
| GB2093027A (en) | 2-amino-3-(halobenzoyl)-methylphenylacetic acids, esters and salts thereof | |
| US4098892A (en) | Nicotinamido-s-triazines | |
| JPS6056996A (ja) | ２′―デオキシ―５―トリフルオロメチルウリジン誘導体及びそれを含有する抗腫瘍剤 | |
| US3005818A (en) | 1-phenyl-2, 3-dimethyl-4-morpholino methyl pyrazolone-(5) compounds | |
| US3592900A (en) | Method for lowering elevated blood sugar levels using a dihydropyridine hydrohalide | |
| US3855283A (en) | Levo 1-amino-3-chloro-2-propanol and acid addition salts thereof | |
| US4920126A (en) | Barbituric acid derivative and treatment of leukemia and tumors therewith | |
| US4180577A (en) | Furo[2, 3d]pyrimidine derivatives and anti-ulcer containing the same |